Pilot evaluation of a personalized commercial program on weight loss, health outcomes, and quality of life
© Society of Behavioral Medicine 2021. All rights reserved. For permissions, please e-mail: journals.permissionsoup.com..
WW is a validated behavioral weight management program that encourages healthy habits. WW developed a method of personalizing the SmartPoints® budget depending on dietary and lifestyle preferences, and participants were placed into one of three plans as a pilot evaluation of this new program. In this 6-month, single-arm pilot study, participants attended weekly workshops and used an app to monitor eating and physical activity. Baseline and 6-month assessments included weight, waist circumference, blood pressure, energy intake, cravings, happiness, health-related quality of life, hunger, and fullness. Of 145 adults assessed at baseline, 126 (87%) provided follow-up data. Pre-post changes showed significant reductions in body weight (7.39% ± 5.93%), calories consumed (24.79% ± 32.35%) and significant improvements in cravings, happiness, all SF-36 scales and hunger but not in fullness. Greater % weight loss was related to greater improvements in happiness (r = .38, p < .001), general health perceptions (r = .29, p = .001), and health change (r = .31, p = .001), and greater reduction in role limitations due to personal or emotional problems (r = .24, p = .01). Greater % reduction in caloric intake was associated with greater reductions in cravings (r = .23, p = .01), as well as with greater improvements in happiness (r = .23, p = .01), physical functioning (r = .23, p = .01), and general health perceptions (r = .23, p = .01). Participants in this modified program achieved significant weight loss, regardless of dietary plan, as well as improvements in a variety of other physical and psychological constructs. Those who achieved greater reductions in weight also reported greater improvements in cravings, happiness and some quality of life measures.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2021 |
---|---|
Erschienen: |
2021 |
Enthalten in: |
Zur Gesamtaufnahme - volume:11 |
---|---|
Enthalten in: |
Translational behavioral medicine - 11(2021), 12 vom: 14. Dez., Seite 2091-2098 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Hales, Sarah B [VerfasserIn] |
---|
Links: |
---|
Themen: |
Cravings |
---|
Anmerkungen: |
Date Completed 16.03.2022 Date Revised 16.03.2022 published: Print Citation Status MEDLINE |
---|
doi: |
10.1093/tbm/ibab110 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM330218174 |
---|
LEADER | 01000naa a22002652 4500 | ||
---|---|---|---|
001 | NLM330218174 | ||
003 | DE-627 | ||
005 | 20231225210818.0 | ||
007 | cr uuu---uuuuu | ||
008 | 231225s2021 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1093/tbm/ibab110 |2 doi | |
028 | 5 | 2 | |a pubmed24n1100.xml |
035 | |a (DE-627)NLM330218174 | ||
035 | |a (NLM)34479369 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Hales, Sarah B |e verfasserin |4 aut | |
245 | 1 | 0 | |a Pilot evaluation of a personalized commercial program on weight loss, health outcomes, and quality of life |
264 | 1 | |c 2021 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Completed 16.03.2022 | ||
500 | |a Date Revised 16.03.2022 | ||
500 | |a published: Print | ||
500 | |a Citation Status MEDLINE | ||
520 | |a © Society of Behavioral Medicine 2021. All rights reserved. For permissions, please e-mail: journals.permissionsoup.com. | ||
520 | |a WW is a validated behavioral weight management program that encourages healthy habits. WW developed a method of personalizing the SmartPoints® budget depending on dietary and lifestyle preferences, and participants were placed into one of three plans as a pilot evaluation of this new program. In this 6-month, single-arm pilot study, participants attended weekly workshops and used an app to monitor eating and physical activity. Baseline and 6-month assessments included weight, waist circumference, blood pressure, energy intake, cravings, happiness, health-related quality of life, hunger, and fullness. Of 145 adults assessed at baseline, 126 (87%) provided follow-up data. Pre-post changes showed significant reductions in body weight (7.39% ± 5.93%), calories consumed (24.79% ± 32.35%) and significant improvements in cravings, happiness, all SF-36 scales and hunger but not in fullness. Greater % weight loss was related to greater improvements in happiness (r = .38, p < .001), general health perceptions (r = .29, p = .001), and health change (r = .31, p = .001), and greater reduction in role limitations due to personal or emotional problems (r = .24, p = .01). Greater % reduction in caloric intake was associated with greater reductions in cravings (r = .23, p = .01), as well as with greater improvements in happiness (r = .23, p = .01), physical functioning (r = .23, p = .01), and general health perceptions (r = .23, p = .01). Participants in this modified program achieved significant weight loss, regardless of dietary plan, as well as improvements in a variety of other physical and psychological constructs. Those who achieved greater reductions in weight also reported greater improvements in cravings, happiness and some quality of life measures | ||
650 | 4 | |a Journal Article | |
650 | 4 | |a Research Support, Non-U.S. Gov't | |
650 | 4 | |a Cravings | |
650 | 4 | |a Diet | |
650 | 4 | |a Happiness | |
650 | 4 | |a Personalized | |
650 | 4 | |a Quality of life | |
650 | 4 | |a Weight loss | |
700 | 1 | |a Schulte, Erica M |e verfasserin |4 aut | |
700 | 1 | |a Turner, Tonya F |e verfasserin |4 aut | |
700 | 1 | |a Malcolm, Robert |e verfasserin |4 aut | |
700 | 1 | |a Wojtanowski, Alexis C |e verfasserin |4 aut | |
700 | 1 | |a Rethorst, Chad |e verfasserin |4 aut | |
700 | 1 | |a Pinto, Angela M |e verfasserin |4 aut | |
700 | 1 | |a Foster, Gary D |e verfasserin |4 aut | |
700 | 1 | |a O'Neil, Patrick M |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Translational behavioral medicine |d 2011 |g 11(2021), 12 vom: 14. Dez., Seite 2091-2098 |w (DE-627)NLM207693765 |x 1613-9860 |7 nnns |
773 | 1 | 8 | |g volume:11 |g year:2021 |g number:12 |g day:14 |g month:12 |g pages:2091-2098 |
856 | 4 | 0 | |u http://dx.doi.org/10.1093/tbm/ibab110 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 11 |j 2021 |e 12 |b 14 |c 12 |h 2091-2098 |